463.39 -4.47 (-0.96%)
After hours: 4:25PM EST
|Bid||466.70 x 800|
|Ask||467.48 x 800|
|Day's range||452.22 - 468.98|
|52-week range||168.65 - 485.00|
|Beta (5Y monthly)||0.90|
|PE ratio (TTM)||81.57|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Offers higher image contrast and sharpness, plus reduces radiation dose by 25% or moreWESTBROOK, Maine, Aug. 12, 2020 /CNW/ -- IDEXX Laboratories, Inc.
WESTBROOK, Maine , April 20, 2020 /CNW/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test for pets. IDEXX is launching the test in response to customer demand and growing evidence that in rare cases pets living with COVID-19 positive humans can be at risk for SARS-CoV-2 infection. The test will be available to veterinarians in North America this week and will continue to roll out across most of the world in the coming weeks, enabled by IDEXX Reference Laboratories, the company's worldwide network of more than 80 laboratories.
Leading Veterinary Diagnostic Company Sees No COVID-19 Cases in Pets